Rasha Al-Lamee's guest appearances

Rasha Al-Lamee

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Parallax by Ankur Kalra

Roxana Mehran

Athena Poppas

Danielle Belardo

Jennifer Mieres

Robert Schwartz

Kavitha Chinnaiyan

Joe Valente

Uncle Joe

Amit Khera

Jeffrey Davis

Colin Berry

Michael Gibson

Martha Gulati

Jag Singh

Nancy M

OwlTail

Recorded before the American Heart Association (AHA) Scientific Sessions 2019, Ankur is joined by Rasha K Al-Lamee, Interventional Cardiologist at Imperial College Healthcare NHS Trust in London and Study Director of the Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) trial. Rasha talks about how she got into academia, the significance of her end-of-training PhD, and what led to the genesis of ORBITA. Ankur and Rasha also discuss the findings and unanswered questions of ORBITA, and how recent research in coronary revascularisation and stable ischemic heart disease has (or has not) changed their clinical practice. Finally, in anticipation of its presentation at AHA 2019, Rasha gives an overview of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). Submit your question to Ankur via: podcast@radciffe-group.com. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Recorded before the American Heart Association (AHA) Scientific Sessions 2019, Ankur is joined by Rasha K Al-Lamee, Interventional Cardiologist at Imperial College Healthcare NHS Trust in London and Study Director of the Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina (ORBITA) trial. Rasha talks about how she got into academia, the significance of her end-of-training PhD, and what led to the genesis of ORBITA. Ankur and Rasha also discuss the findings and unanswered questions of ORBITA, and how recent research in coronary revascularisation and stable ischemic heart disease has (or has not) changed their clinical practice. Finally, in anticipation of its presentation at AHA 2019, Rasha gives an overview of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA). Submit your question to Ankur via: podcast@radciffe<a href="http://-group.com" rel="nofollow" target="_blank">-group.com</a>. Hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

17: Rasha Al-Lamee on ORBITA, ISCHEMIA, coronary revascularisation & stable ischemic heart disease

William Boden

In this interview, William Boden and Rasha Al-Lamee discuss insights from ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina), the first placebo-controlled trial of percutaneous coronary intervention in stable coronary artery disease.

<p>In this interview, William Boden and Rasha Al-Lamee discuss insights from ORBITA (Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina), the first placebo-controlled trial of percutaneous coronary intervention in stable coronary artery disease.</p>

ACCEL Lite: Featured ACCEL Interview With William Boden and Rasha Al-Lamee